Mannkind (MNKD) Shareholder's Equity (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.02% |
| Dec 31, 2025 | -14.52% |
| Sep 30, 2025 | 19.06% |
| Jun 30, 2025 | 6.10% |
| Mar 31, 2025 | 25.63% |
| Dec 31, 2024 | 62.46% |
| Sep 30, 2024 | 7.02% |
| Jun 30, 2024 | 1.82% |
| Mar 31, 2024 | 6.58% |
| Dec 31, 2023 | 2.23% |
| Sep 30, 2023 | 3.34% |
| Jun 30, 2023 | -1.99% |
| Mar 31, 2023 | -1.94% |
| Dec 31, 2022 | -5.41% |
| Sep 30, 2022 | 3.80% |
| Jun 30, 2022 | -6.46% |
| Mar 31, 2022 | -10.85% |
| Dec 31, 2021 | -13.35% |
| Sep 30, 2021 | -0.62% |
| Jun 30, 2021 | -5.72% |
| Mar 31, 2021 | 3.77% |
| Dec 31, 2020 | 3.22% |
| Sep 30, 2020 | -3.73% |
| Jun 30, 2020 | 9.26% |
| Mar 31, 2020 | -3.95% |
| Dec 31, 2019 | -3.15% |
| Sep 30, 2019 | 5.76% |
| Jun 30, 2019 | -4.25% |
| Mar 31, 2019 | -7.38% |
| Dec 31, 2018 | 14.78% |
| Sep 30, 2018 | 0.57% |
| Jun 30, 2018 | 7.43% |
| Mar 31, 2018 | -3.95% |
| Dec 31, 2017 | 14.45% |
| Sep 30, 2017 | -13.46% |
| Jun 30, 2017 | -11.33% |
| Mar 31, 2017 | -8.24% |
| Dec 31, 2016 | 23.08% |
| Sep 30, 2016 | 34.89% |
| Jun 30, 2016 | 1.84% |
| Mar 31, 2016 | -6.60% |
| Dec 31, 2015 | -181.23% |
| Sep 30, 2015 | -7.88% |
| Jun 30, 2015 | -19.01% |
| Mar 31, 2015 | -31.53% |
| Dec 31, 2014 | -81.35% |
| Sep 30, 2014 | 12.29% |
| Jun 30, 2014 | -364.47% |
| Mar 31, 2014 | 157.10% |
| Dec 31, 2013 | 81.69% |
| Sep 30, 2013 | -10.08% |
| Jun 30, 2013 | -3.78% |
| Mar 31, 2013 | -32.64% |
| Dec 31, 2012 | 59.93% |
| Sep 30, 2012 | -13.04% |
| Jun 30, 2012 | 11.90% |
| Mar 31, 2012 | 11.56% |
| Dec 31, 2011 | -11.70% |
| Sep 30, 2011 | -14.44% |